You could check their website.
ASHG 2013. Oxford Nanopore will be exhibiting at ASHG 2013 in Boston, 22-26 October. http://www.ashg.org/2013meeting/
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by GenoMax View PostThey just raised $64 Million this month: http://nextgenseek.com/2013/10/oxfor...es-64-million/ Clearly investors must have seen something that we do not have access to (yet).
Leave a comment:
-
Originally posted by bstamps View PostI'm guessing
Either they release something, or risk losing funding from investors at this point. My bet is that they release the Minion sooner than the Gridion.Last edited by GenoMax; 10-18-2013, 10:48 AM.
Leave a comment:
-
I'm guessing
A) 100%
B) 75/25. Either they release something, or risk losing funding from investors at this point. My bet is that they release the Minion sooner than the Gridion.
Leave a comment:
-
So.
ASHG next week.
Any care to give odds on ONT:
A) Being present?
B) Announcing anything? (Announcing no announcements does not count)
To aid in your handicapping, a certain Clive Brown tweeted:
Clive G. Brown @Clive_G_Brown 9 Oct
I've reluctantly rejoined twitter purely so that I can make one tweet - when the appropriate time arises ...
Leave a comment:
-
Originally posted by nickloman View PostGiven that they are continuously screening new and better pores and that is in fact one of the cool things about a biological nanopore (just like other sequencing companies regularly screen for new polymerases), I didn't necessarily see that as reflective of where they are in the product development pipeline.
We all hope they will stop the screening at some point and release the first product we can use.
Leave a comment:
-
Originally posted by ECO View PostSeriously though, having been through the bring up of a single molecule sequencer...if the CTO is opining in a bar to a blogger about improving consensus accuracy by throwing in multiple types of pores...they are a LONG way from finalizing a chemistry, let alone stabilizing and commercializing it.
Given that they are continuously screening new and better pores and that is in fact one of the cool things about a biological nanopore (just like other sequencing companies regularly screen for new polymerases), I didn't necessarily see that as reflective of where they are in the product development pipeline.
Leave a comment:
-
Waaaaaa we made promises we couldn't keep to get attention and funding...and now people expect us to keep them!
<tiny violin playing>
Seriously though, having been through the bring up of a single molecule sequencer...if the CTO is opining in a bar to a blogger about improving consensus accuracy by throwing in multiple types of pores...they are a LONG way from finalizing a chemistry, let alone stabilizing and commercializing it.
Happy to eat words. Actually I love having my pessimism proven wrong.
And I hope I'm not off Clive's list. I could do some long range clinical haplotyping pretty easily!
Leave a comment:
-
Originally posted by Clive
([urlhttp://pathogenomics.bham.ac.uk/blog/2013/03/a-chat-with-oxford-nanopores-clive-brown-at-agbt-2013[/url])
“We didn’t even know that long reads were so important to people until after that AGBT presentation.”Last edited by Jeremy; 03-06-2013, 05:41 PM.
Leave a comment:
-
Originally posted by krobison View PostWhat? You weren't out on the strand digging through sand like a madman?
Leave a comment:
-
Originally posted by krobison View PostWhat? You weren't out on the strand digging through sand like a madman?
I should have been stalking the bar, apparently.
Leave a comment:
-
Originally posted by krobison View PostWhat? You weren't out on the strand digging through sand like a madman?
Leave a comment:
-
Originally posted by seqnextgen View PostAFAIK, nothing..... no data, no status update, not even a cool USB sequencer full with data found in a bar
Leave a comment:
Latest Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 08:47 AM
|
0 responses
16 views
0 likes
|
Last Post
by seqadmin
Yesterday, 08:47 AM
|
||
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
60 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
60 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
54 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
Leave a comment: